NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 52 filers reported holding NOVELION THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,000 | -3.4% | 39,891 | 0.0% | 0.00% | – |
| Q3 2019 | $29,000 | -6.5% | 39,891 | 0.0% | 0.00% | – |
| Q2 2019 | $31,000 | -36.7% | 39,891 | 0.0% | 0.00% | – |
| Q1 2019 | $49,000 | +44.1% | 39,891 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | -71.2% | 39,891 | 0.0% | 0.00% | – |
| Q3 2018 | $118,000 | -19.7% | 39,891 | 0.0% | 0.00% | – |
| Q2 2018 | $147,000 | +5.0% | 39,891 | 0.0% | 0.00% | – |
| Q1 2018 | $140,000 | +12.9% | 39,891 | 0.0% | 0.00% | – |
| Q4 2017 | $124,000 | -55.7% | 39,891 | 0.0% | 0.00% | – |
| Q3 2017 | $280,000 | -23.9% | 39,891 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $368,000 | -14.0% | 39,891 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $428,000 | +25.5% | 39,891 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $341,000 | – | 40,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,524,034 | $12,832,000 | 7.64% |
| Healthcare Value Capital, LLC | 831,440 | $7,001,000 | 7.50% |
| ARMISTICE CAPITAL, LLC | 1,420,000 | $11,956,000 | 2.83% |
| Sarissa Capital Management LP | 1,025,000 | $8,630,000 | 2.38% |
| Broadfin Capital, LLC | 1,948,554 | $16,407,000 | 1.82% |
| JW Asset Management, LLC | 324,280 | $2,731,000 | 1.82% |
| Tiger Legatus Capital Management, LLC | 320,000 | $2,694,000 | 1.00% |
| Kingstown Capital | 599,998 | $5,052,000 | 0.50% |
| KNOTT DAVID M | 109,184 | $919,000 | 0.46% |
| Ancora Advisors LLC | 560,613 | $4,721,000 | 0.34% |